QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers Wellchange Holdings (NASDAQ: WCT) shares rose 10.4% to $0.4 during Thursday's after-market session. The company...

 beijing-tongmei-xtal-technology--a-subsidiary-of-axt-receives-export-permits-from-china-for-indium-phosphide-believe-export-permit-will-result-in-several-million-dollars-in-revenue-that-was-not-included-in-q3-forecast

 - SEC Filing

 wedbush-maintains-outperform-on-axt-lowers-price-target-to-41

Wedbush analyst Matt Bryson maintains AXT (NASDAQ:AXTI) with a Outperform and lowers the price target from $4.25 to $4.1.

 axt-q2-eps-016-misses-014-estimate-sales-1797m-miss-2085m-estimate

AXT (NASDAQ:AXTI) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 10.3...

 axts-earnings-a-preview
AXT's Earnings: A Preview
07/30/2025 21:02:25

 b-riley-securities-maintains-buy-on-axt-lowers-price-target-to-43

B. Riley Securities analyst Dave Kang maintains AXT (NASDAQ:AXTI) with a Buy and lowers the price target from $4.5 to $4.3.

 axt-lowers-q2-sales-guidance-from-20000m-22000m-to-17500m-18000m-vs-20852m-est

AXT (NASDAQ:AXTI) lowers Q2 sales outlook from $20.000 million-$22.000 million to $17.500 million-$18.000 million vs $20.852 mi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION